| | CLASS NOTES |
| 1 | DF | DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) {29} |
| | ****************************** |
| | *NOTE: See subclasses 800-809* |
| | *for art collections pertain-* |
| | *ing to subclasses 1-21. ....* |
| | ****************************** |
| 769 | DF | DESIGNATED INORGANIC NONACTIVE INGREDIENT OR ELEMENTAL MATERIAL OTHER THAN WATER {2} |
| 772 | DF | DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING OTHER THAN HYDROCARBON {9} |
| 788.1 | DF | SOLID SYNTHETIC ORGANIC POLYMER DERIVED SOLELY FROM HYDROCARBON REACTANTS AS DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING |
| 789 | DF | MISCELLANEOUS (e.g., HYDROCARBONS, etc.) |
| | ****************************** |
| | CROSS-REFERENCE ART COLLECTIONS PERTAINING TO CLASS 514 (see subclasses 800-975 below) |
| | ****************************** |
| | ****************************** |
| | *PEPTIDE AND PROTEIN ART.....* |
| | *COLLECTIONS PERTAINING TO...* |
| | *CLASS 514. .................* |
| | ****************************** |
| 800 | DF | LHRH LIKE |
| 801 | DF | COLLAGEN, GELATIN OR DERIVATIVES THEREOF |
| 802 | DF | FIBRINOPEPTIDES, BLOOD-COAGULATION FACTORS OR DERIVATIVES |
| 803 | DF | KININ OR DERIVATIVES |
| 804 | DF | PHECMYCIN SERIES OR DERIVATIVES |
| 805 | DF | ADRENOCORTICOTROPIC HORMONE OR DERIVATIVES |
| 806 | DF | SOMATOSTATIN OR DERIVATIVES |
| 807 | DF | OXYTOXIN, VASOPRESSIN OR DERIVATIVES |
| 808 | DF | CALCITONIN OR DERIVATIVES |
| 809 | DF | ENKEPHALIN OR ENDORPHIN OR DERIVATIVES |
| | ****************************** |
| | *SPECIFICALLY DISCLOSED......* |
| | *DISEASE CONDITION AND.......* |
| | *PHARMACEUTICAL EFFECT FOR...* |
| | *PATENTS ISSUED SUBSEQUENT...* |
| | *TO JAN 1, 1965. ............* |
| | ****************************** |
| 810 | DF | ADDICTION {3} |
| 814 | DF | ANEMIA {1} |
| 816 | DF | ANESTHETIC, GENERAL |
| 817 | DF | ANESTHETIC, TOPICAL |
| 818 | DF | ANESTHETIC, LOCAL |
| 819 | DF | ANTACID, ORAL {1} |
| 821 | DF | ANTIARRHYTHMIC |
| 822 | DF | ANTICOAGULATION |
| 823 | DF | ANTIDOTE |
| 824 | DF | ARTERIOSCLEROSIS |
| 825 | DF | ARTHRITIS |
| 826 | DF | ASTHMA |
| 827 | DF | ASTRINGENT, NONFACIAL {1} |
| 829 | DF | BITE OR STING {2} |
| 832 | DF | BLOOD SUBSTITUTE |
| 833 | DF | BLOOD PLASMA EXTENDER |
| 834 | DF | COAGULANT |
| 835 | DF | CARIES |
| 836 | DF | CHELATE |
| 837 | DF | CHOLERA |
| 838 | DF | CIRRHOSIS |
| 839 | DF | CONTACT LENS TREATMENT {1} |
| 841 | DF | CONTRACEPTIVE {2} |
| 844 | DF | COSMETIC, FACIAL {4} |
| 849 | DF | COUGH AND COLD PREPARATION {1} |
| 851 | DF | CYSTIC FIBROSIS |
| 852 | DF | DANDRUFF |
| 853 | DF | DECONGESTANT {2} |
| * | DF | DERMATITIS {8} |
| 866 | DF | DIABETES |
| 867 | DF | DIARRHEA |
| 868 | DF | DISTEMPER |
| 869 | DF | DIURETIC |
| 870 | DF | EDEMA {1} |
| 872 | DF | EMESIS (motion sickness-nausea) |
| 873 | DF | EMOLLIENT |
| 874 | DF | ESTROGENIC AGENT (noncontraceptive) |
| 875 | DF | FLEA CONTROL {1} |
| 877 | DF | GALLSTONE |
| 878 | DF | GERIATRICS {1} |
| 880 | DF | HAIR TREATMENT (therapeutic-scalp) {1} |
| 882 | DF | HEMORRHOID PREPARATION |
| 883 | DF | HODGKIN'S DISEASE |
| 884 | DF | HYPOGLYCEMIA |
| 885 | DF | IMMUNE RESPONSE AFFECTING DRUG |
| 886 | DF | INFLAMMATION, SKIN {1} |
| 888 | DF | INFLUENZA |
| 889 | DF | INTERFERON INDUCER |
| 890 | DF | IRRITANT (e.g., tear gas, etc.) |
| 891 | DF | KIDNEY STONE |
| 892 | DF | LAXATIVE |
| 893 | DF | LIVER DISORDER {1} |
| 895 | DF | MALARIA |
| 896 | DF | MEASLES {1} |
| 898 | DF | MENINGITIS |
| 899 | DF | MENSTRUAL DISORDER |
| * | DF | MOUTH TREATMENT {3} |
| 903 | DF | MULTIPLE SCLEROSIS |
| 904 | DF | MULTIPLE VITAMINS {1} |
| 906 | DF | MUSCLE RELAXANT |
| 907 | DF | MUSCULAR DYSTROPHY |
| 908 | DF | LEUKEMIA |
| 909 | DF | OBESITY {2} |
| 912 | DF | OPHTHALMIC {3} |
| 916 | DF | PYRETIC |
| 917 | DF | RADIOACTIVE, ANTI- |
| 918 | DF | REPELLENT {2} |
| 921 | DF | SHOCK |
| 922 | DF | SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT |
| 923 | DF | SLEEP AID (Insomnia) |
| 924 | DF | TUBERCULOSIS |
| 925 | DF | ULCER TREATMENT {3} |
| 929 | DF | VASODILATOR |
| 930 | DF | VASOCONSTRICTOR (nondecongestant) |
| 931 | DF | VENERAL DISEASE {3} |
| 935 | DF | UTERINE MOTILITY |
| | ****************************** |
| | *ART COLLECTIONS 936-975.....* |
| | *EXCLUDE PRE 1965 PATENTS....* |
| | *ISSUED FROM 260 AND 530.....* |
| | *SERIES CLASSES. ............* |
| | *............................* |
| | *LIQUID CARRIER, DILUENT OR..* |
| | *SOLVENT.....................* |
| | *............................* |
| | *ART COLLECTIONS 936-975.....* |
| | *EXCLUDE PRE 1965 PATENTS....* |
| | *ISSUED FROM CLASS 260 AND...* |
| | *THE CLASS 532-570 SERIES....* |
| | *AND CLASS 585. .............* |
| | ****************************** |
| * | DF | LIQUID CARRIER, DILUENT OR SOLVENT |
| 936 | DF | DMSO CONTAINING |
| 937 | DF | DISPERSION OR EMULSION {1} |
| 944 | DF | GEL |
| 945 | DF | FOAM |
| 946 | DF | PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED) {1} |
| * | DF | SOLID CARRIER OR SOLID DILUENT |
| 948 | DF | SOLID CANDY TYPE |
| 949 | DF | NATURALLY DERIVED CLAY (E.G., BENTONITE, ETC.) |
| 950 | DF | MACROMOLECULAR (OTHER THAN SYNTHETIC RESINS) |
| 951 | DF | POWDERS, GRANULES OR PARTICLES OF SPECIFIED MESH OR PARTICLE SIZE {1} |
| 953 | DF | SHAPED FORMS ADAPTED FOR NONINGESTIBLE USE OTHER THAN SUPPOSITORY TYPE (E.G., FILMS, INSERTS, ETC.) {2} |
| * | DF | GASEOUS OR GAS EMITTING CARRIER OR PROPELLANT |
| 957 | DF | VAPOR EMMITTING COMPOSITION |
| 958 | DF | FOR SMOKING OR INHALING |
| 959 | DF | BREATHING GASES |
| * | DF | PILL, LOZENGE, TABLET OR CAPSULE |
| 960 | DF | SIGNIFICANT, TABLET FORMULATION (E.G., DESIGNATED EXCIPIENT, DISINTEGRANT, GLYDENT OR LUBRICANT, ETC.) {1} |
| 962 | DF | CAPSULE (E.G., GELATIN, ETC.) {1} |
| 964 | DF | SUSTAINED OR DIFFERENTIAL RELEASE TYPE {1} |
| * | DF | SUPPOSITORY, BOUGIE OR BASE |
| 966 | DF | RECTAL |
| 967 | DF | VAGINAL |
| 968 | DF | URETHRAL |
| 969 | DF | OINTMENT OR SALVE BASE |
| * | DF | SPECIAL DESIGNATED INGREDIENT |
| 970 | DF | CONTAINING DESIGNATED INGREDIENT TO STABILIZE AN ACTIVE INGREDIENT {3} |
| 974 | DF | CONTAINING DESIGNATED INGREDIENT TO REDUCE NOXIOUS EFFECTS OF ACTIVE INGREDIENT (E.G., TASTE MASKING, ODOR REDUCING, ETC.) |
| 975 | DF | CHARACTERIZED BY THE DESIGNATED SURFACTANT USED |
